107 related articles for article (PubMed ID: 32930967)
1. Correction to: Pharmacokinetics and Dialyzability of a Single Oral Dose of Amenamevir, an Anti-Herpes Drug, in Hemodialysis Patients.
Tsuruoka S; Endo T; Seo M; Hashimoto N
Adv Ther; 2020 Nov; 37(11):4758-4764. PubMed ID: 32930967
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and Dialyzability of a Single Oral Dose of Amenamevir, an Anti-Herpes Drug, in Hemodialysis Patients.
Tsuruoka S; Endo T; Seo M; Hashimoto N
Adv Ther; 2020 Jul; 37(7):3234-3245. PubMed ID: 32440976
[TBL] [Abstract][Full Text] [Related]
3. The Influence of Hepatic and Renal Impairment on the Pharmacokinetics of a Treatment for Herpes Zoster, Amenamevir (ASP2151): Phase 1, Open-Label, Single-Dose, Parallel-Group Studies.
Kusawake T; Kowalski D; Takada A; Kato K; Katashima M; Keirns JJ; Lewand M; Lasseter KC; Marbury TC; Preston RA
Adv Ther; 2017 Dec; 34(12):2612-2624. PubMed ID: 29134428
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and Safety of Amenamevir in Healthy Subjects: Analysis of Four Randomized Phase 1 Studies.
Kusawake T; Keirns JJ; Kowalski D; den Adel M; Groenendaal-van de Meent D; Takada A; Ohtsu Y; Katashima M
Adv Ther; 2017 Dec; 34(12):2625-2637. PubMed ID: 29134426
[TBL] [Abstract][Full Text] [Related]
5. Dialyzability and pharmacokinetics of sitafloxacin following multiple oral dosing in infected hemodialysis patients.
Tsuruoka S; Yokota N; Hayasaka T; Saito T; Yamagata K
Ther Apher Dial; 2013 Jun; 17(3):319-24. PubMed ID: 23735148
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic Evaluation of the Interactions of Amenamevir (ASP2151) with Ketoconazole, Rifampicin, Midazolam, and Warfarin in Healthy Adults.
Kusawake T; den Adel M; Groenendaal-van de Meent D; Garcia-Hernandez A; Takada A; Kato K; Ohtsu Y; Katashima M
Adv Ther; 2017 Nov; 34(11):2466-2480. PubMed ID: 29076107
[TBL] [Abstract][Full Text] [Related]
7. In vivo evaluation of drug dialyzability in a rat model of hemodialysis.
Fukunaga M; Kadowaki D; Mori M; Hagiwara S; Narita Y; Saruwatari J; Tanaka R; Watanabe H; Yamasaki K; Taguchi K; Ito H; Maruyama T; Otagiri M; Hirata S
PLoS One; 2020; 15(6):e0233925. PubMed ID: 32530952
[TBL] [Abstract][Full Text] [Related]
8. Dialyzability of Faropenem in Infected Patients on Chronic Hemodialysis.
Hasegawa G; Tsuruoka S; Ushijima K; Maeda A; Hayasaka T; Saito T; Harada K; Fujimura A
Ther Apher Dial; 2017 Feb; 21(1):52-56. PubMed ID: 27629941
[TBL] [Abstract][Full Text] [Related]
9. Helicase-primase inhibitor amenamevir for herpesvirus infection: Towards practical application for treating herpes zoster.
Shiraki K
Drugs Today (Barc); 2017 Nov; 53(11):573-584. PubMed ID: 29451274
[TBL] [Abstract][Full Text] [Related]
10. An Open-Label, Single-Dose, Human Mass Balance Study of Amenamevir in Healthy Male Adults.
Kato K; den Adel M; Groenendaal-van de Meent D; Ohtsu Y; Takada A; Katashima M
Clin Pharmacol Drug Dev; 2019 Jul; 8(5):595-602. PubMed ID: 30412362
[TBL] [Abstract][Full Text] [Related]
11. Statistical analysis of Amenamevir (ASP2151) between pharmacokinetics and clinical efficacies with non-linear effect model for the treatment of genital herpes.
Takada A; Katashima M; Kaibara A; Sawamoto T; Zhang W; Keirns J
Clin Pharmacol Drug Dev; 2014 Sep; 3(5):365-70. PubMed ID: 27129009
[TBL] [Abstract][Full Text] [Related]
12. Absorption, Distribution, Metabolism, and Excretion of the Novel Helicase-Primase Inhibitor, Amenamevir (ASP2151), in Rodents.
Ohtsu Y; Susaki Y; Noguchi K
Eur J Drug Metab Pharmacokinet; 2018 Dec; 43(6):693-706. PubMed ID: 29748821
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of the pharmacokinetics, pharmacodynamics, and dialyzability of verapamil in chronic hemodialysis patients.
Hanyok JJ; Chow MS; Kluger J; Izard MW
J Clin Pharmacol; 1988 Sep; 28(9):831-6. PubMed ID: 3230150
[TBL] [Abstract][Full Text] [Related]
14. Amenamevir, a novel helicase-primase inhibitor, for treatment of herpes zoster: A randomized, double-blind, valaciclovir-controlled phase 3 study.
Kawashima M; Nemoto O; Honda M; Watanabe D; Nakayama J; Imafuku S; Kato T; Katsuramaki T;
J Dermatol; 2017 Nov; 44(11):1219-1227. PubMed ID: 28681394
[TBL] [Abstract][Full Text] [Related]
15. Dialyzability and pharmacokinetics of indomethacin in adult patients with end-stage renal disease.
Skoutakis VA; Acchiardo SR; Carter CA; Wojciechowski NJ; Straughn AB; Meyer MC
Drug Intell Clin Pharm; 1986 Dec; 20(12):956-60. PubMed ID: 3816544
[TBL] [Abstract][Full Text] [Related]
16. Elimination of intravenous alendronate by hemodialysis: A kinetic study.
Iseri K; Watanabe M; Lee XP; Yamada M; Ryu K; Iyoda M; Uchida N; Sato K; Shibata T
Hemodial Int; 2019 Oct; 23(4):466-471. PubMed ID: 31328884
[TBL] [Abstract][Full Text] [Related]
17. Clearance of cardiovascular medications during hemodialysis.
Tieu A; Leither M; Urquhart BL; Weir MA
Curr Opin Nephrol Hypertens; 2016 May; 25(3):257-67. PubMed ID: 27023840
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacological profiles and clinical effects of amenamevir tablet as treatments for herpes zoster].
Maeda H; Nakamura H; Kikukawa Y
Nihon Yakurigaku Zasshi; 2019; 153(1):35-43. PubMed ID: 30643090
[TBL] [Abstract][Full Text] [Related]
19. Amenamevir: Studies of Potential CYP2C8- and CYP2B6-Mediated Pharmacokinetic Interactions With Montelukast and Bupropion in Healthy Volunteers.
Dennison J; Puri A; Warrington S; Endo T; Adeloye T; Johnston A
Clin Pharmacol Drug Dev; 2018 Nov; 7(8):860-870. PubMed ID: 29870591
[TBL] [Abstract][Full Text] [Related]
20. Antiviral efficacy of the helicase-primase inhibitor amenamevir in murine models of severe herpesvirus infection.
Katsumata K; Chono K; Suzuki H
Biochem Pharmacol; 2018 Dec; 158():201-206. PubMed ID: 30365949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
